Bored Review NM4 - Comprehensive Clinical Guide to Inclusion Body Myositis and Inflammatory Myopathies

Evaluation of Muscle Biopsy and Pathological Inflammation

  • Initial Pathological Features: Inflammation in muscle biopsies can present with specific facial features, and may involve a lid cone or modula structure during the biopsy process.

  • Inflammatory Characteristics:

    • Patient may exhibit necrotic inflammation.

    • Nana necrotic muscle fiber inflammation is a key finding.

    • Pathologists may observe cellular invasion within the muscle fibers.

European Neuromuscular Criteria for Inclusion Body Myositis (IBM) Diagnosis

  • General Diagnostic Framework: The diagnosis follows a step-by-step process involving clinical presentation, mandatory investigations, and supportive features.

  • Step 1: Clinical Presentation Criteria

    • Age of Onset: Traditional criteria required the patient to be older than 50 years; however, the new criteria specify an age of 45 years or older.

    • Duration: The condition is chronic, defined as at least more than one year of progressive muscle weakness.

    • Creatine Kinase (CK) Levels: Typically, the CK level is less than 15 times (15×15 \times) the upper limit of normal (ULN\text{ULN}).

    • Common (Typical) Presentation:

      • Characterized by "common IBM muscle involvement pattern."

      • Involves deep finger flexion weakness.

      • Involves knee extensor weakness.

  • Uncommon (Atypical) Presentation Criteria:

    • Age of onset less than 45 years old.

    • Acute or subacute onset, or less than one year of progressive weakness.

    • CK levels exceeding 15 times (15×15 \times) the upper limit of normal.

    • Presence of acute pulmonary edema.

    • Axial weakness.

    • Isolated dysphagia.

    • Foot drop.

    • Facial diplegia.

    • Proximal limb weakness in the absence of finger flexion weakness and knee extension weakness.

Investigation Requirements for IBM

  • Mandatory Investigation Findings:

    • Evidence of endomysial lymphocytes surrounding nonnecrotic muscle fibers.

    • This may occur with or without cellular invasion.

    • Specific biopsy finding: nonnecrotic muscle fiber surrounded by inflammation.

  • Supportive Features for Diagnosis:

    1. Pathology (Mitochondrial Abnormality): Identified via Mitochondrial stain, specifically the Succinate Dehydrogenase (SDH\text{SDH}) stain, which shows cycloid abnormal findings.

    2. Laboratory Tests: Detection of anti-cN1AcN1A antibodies (anti-cytosolic 5’-nucleotidase 1A\text{anti-cytosolic 5'-nucleotidase 1A}).

    3. Muscle Imaging: Typical appearance on Muscle MRI or diagnostic findings on ultrasound.

Diagnostic Decision Logic for IBM

  • Category: Definitive IBM (Common Presentation):

    • Requires a typical presentation (Finger flexion weakness + knee extension weakness) PLUS mandatory investigation findings (nonnecrotic muscle fiber inflammation).

  • Category: Probable IBM (Typical but Partial):

    • Requires finger flexion weakness OR knee extension weakness PLUS mandatory investigation findings PLUS at least one supportive investigation finding.

  • Category: IBM (Uncommon Presentation):

    • Requires an uncommon clinical presentation PLUS mandatory investigation findings PLUS at least two out of four supportive findings.

Differential Diagnosis and Alternative Diagnosis Indicators

  • Red Flags for Alternative Diagnoses: Certain factors suggest a diagnosis other than IBM is more likely:

    • Family History: IBM is usually a sporadic disease. A positive family history of any neuromuscular disease suggests a genetic or alternative condition.

    • Electromyography (EMG): Findings not consistent with IBM (e.g., lack of denervation). Expected IBM findings include positive shortwave or fibrillation.

    • Specific Antibodies: Presence of myocyte-specific antibodies such as LJO1LJO1 (Likely referring to anti-Jo-1) or antigens associated with antisynthetase syndrome (e.g., LUOLUO).

Serum Enzymes and Biomarkers in Myopathy vs. Liver Disease

  • Liver-Specific Markers: Gamma-glutamyl transferase (GGTGGT) is elevated in patients with liver disease but remains normal in patients with myopathies. This makes it a specific marker for liver damage.

  • Shared Markers: The following enzymes can be elevated in both liver disease and muscle damage (myopathy), making them less specific:

    • Alanine aminotransferase (ALTALT).

    • Aspartate aminotransferase (ASTAST).

    • Aldolase.

    • Lactate dehydrogenase (LDHLDH).

  • Clinical Application: If a patient has a high liver function test (LFT\text{LFT}) and high GGTGGT, it indicates liver damage. If GGTGGT is normal despite other elevations, muscle damage should be suspected.

Dermatomyositis Specific Antibodies and Malignancy Risks

  • Anti-TIF1γTIF1 \gamma (Transcriptional Intermediary Factor 1-gamma):

    • Most strongly associated with malignancy (cancer) in adults.

    • Patients positive for this antibody require maintenance screening for malignancy for at least three years.

    • In children, it causes severe skin disease, including palmar hyperkeratotic papules and a psoriasis-like syndrome.

  • Anti-Mi2Mi-2:

    • Associated with a very benign course.

    • Higher prevalence in Hispanic populations.

    • Usually presents with minimal or no muscle weakness.

  • Anti-MDA5MDA5 (Melanoma Differentiation-Associated Protein 5):

    • Associated with Interstitial Lung Disease (ILD\text{ILD}).

    • Associated with cardiopulmonary syndrome.

    • Clinical signs include skin ulcerations and oral restorations/ulcerations.

  • Anti-NXP2NXP2 (Nuclear Matrix Protein 2):

    • Seen in pediatric/juvenile dermatomyositis.

    • Associated with cancer risk, though lower than anti-TIF1γTIF1 \gamma.

    • Associated with dysphagia.

  • Anti-SAESAE (Small Ubiquitin-like Modifier Activating Enzyme):

    • Characterized by skin manifestations presenting before the onset of muscle weakness.

Clinical Characterization of Myotonia

  • Paramyotonia Congenita:

    • Demonstrable myotonia that worsens with repetition of the eliciting maneuver (paradoxical myotonia).

    • Worsens significantly in cold environments.

  • Myotonic Dystrophy (Type 1 and Type 2):

    • Characterized by the "warm-up" phenomenon.

    • Myotonia improves with the repetition of the maneuver.

  • Other Related Conditions: Anderson-Tawil Syndrome and Channel Myotonia possess distinct clinical behaviors regarding repetition.

Questions & Discussion

  • Question: Which of the following serum enzymes are elevated in patients with liver disease and normal in patients with myopathies? (Options: Alanine aminotransferase, Aldolase, Aspartate aminotransferase, Gamma glutamyl transferase, Lactate dehydrogenase).

    • Response: Gamma glutamyl transferase (GGTGGT). It is specific to the liver and not for muscle.

  • Question: Which dermatomyositis specific antibody is most associated with malignancy?

    • Response: TIF1γTIF1 \gamma. Patients require at least three years of cancer screening.

  • Question: Which of the following conditions have demonstrable myotonia that worsen with repetition of the eliciting maneuver?

    • Response: Baromyotonia (Paramyotonia congenita), due to paradoxical myotonia. Classically, myotonic dystrophy improves with repetition.